About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
Clinical StudiesFirst patient suffering from severe symptomatic Aortic Stenosis treated with our Non-Invasive Ultrasound Therapy at CHU Lille Sep 29, 2022 READ MORE
Aortic StenosisRétrécissement de la valve aortique, un traitement par ultrasons Jul 20, 2022 READ MORE
Aortic StenosisSténose aortique : la technologie à ultrasons qui pourrait changer la donne Jun 22, 2022 READ MORE
Press ReleaseCardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. Jun 14, 2022 READ MORE
Press ReleaseCardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. May 2, 2022 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
